Advertisement

OTHER NEWS - Oct. 8, 1991

Share
From Times Staff and Wire Reports

Upjohn Says Stock Report Was Phony: Upjohn Co. officials asked the SEC to investigate what it said was a phony report of an offer to buy 50 million shares of the drug company’s stock. The report, sent by facsimile to brokerages, said a cash offer of $69.50 a share would begin Wednesday. The company’s stock fell 25 cents a share Monday to $43.25 on the New York Stock Exchange.

Advertisement